Empagliflozin Tablets

Intended to relieve elevated blood sugar to support glycaemic stability and target renal glucose clearance.

Dosage

Pack size

The exact manufacturer offered is confirmed by the fulfilment partner before supply.

Prescription and consultation requirements for Empagliflozin Tablets vary by destination and are determined by the fulfilment partner.

Empagliflozin Tablets details

Conditions: Type 2 Diabetes Mellitus · Heart Failure · Cardiovascular Mortality Reduction
Alternative names: jardiance
Therapeutic class: Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
Pharmacological class: SGLT2 Inhibitor
Known off-label uses: chronic kidney disease
Contraindications: severe renal impairment (for glycaemic control); diabetic ketoacidosis
Minor side effects: increased urination; nausea
Moderate side effects: urinary tract infection; genital fungal infection; dyslipidaemia
Dosage forms: Tablet
Administration route: Oral use
Supply category: Prescription-only medicine (POM)
Onset Time: 1–2 weeks
Duration: 24 hours
Storage instructions: Store below 25°C.
Drug interactions: Insulin; Diuretics
Age restrictions: Approved for adults.

Serious side effects

fournier's gangrene, requires immediate medical attention; diabetic ketoacidosis, requires immediate medical attention

Patient summary

intended to relieve elevated blood sugar to support glycaemic stability and target renal glucose clearance.

Mechanism of action

Blocks SGLT2 in renal proximal tubules, lowering glucose reabsorption so that excess blood sugar is lost through urination.

Pregnancy and breastfeeding

TGA Category C: Avoid during second and third trimesters. Breastfeeding: Not recommended.

Empagliflozin Tablets is a generic medicine sold under the name of its active ingredient, Empagliflozin, rather than under a brand.

The fulfilment partner confirms the offered manufacturer and product before supply.
Check the active ingredient, strength, form and pack shown at checkout before confirming an order.